Intracardiac thrombus and cerebral infarction in a patient with duchenne muscular dystrophy

Journal of Clinical Neuromuscular Disease

Volumn 11, Issue 2, 2009, Pages 79-80

  Gimenez Muñoz, Alvaro ^a   Capablo, Jose L ^a   Alarcia, Raquel ^a   Torné, Laura ^a   Errea, Jose M ^b  

^a HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^b HOSPITAL DE BARBASTRO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DYSTROPHIN;

ADULT; BRAIN INFARCTION; CASE REPORT; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; DUCHENNE MUSCULAR DYSTROPHY; DYSARTHRIA; ELECTROCARDIOGRAM; FACIAL NERVE PARALYSIS; HEART LEFT VENTRICLE FAILURE; HEMIPARESIS; HUMAN; INTRACARDIAC THROMBOSIS; LETTER; MALE; MUSCULAR DYSTROPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RESPIRATORY FAILURE;

ADRENERGIC BETA-ANTAGONISTS; ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTICOAGULANTS; CARDIOMYOPATHY, DILATED; CEREBRAL INFARCTION; DIURETICS; ECHOCARDIOGRAPHY; FATAL OUTCOME; HEART DISEASES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MUSCULAR DYSTROPHY, DUCHENNE; THROMBOSIS;

EID: 75149166169     PISSN: 15220443     EISSN: 15371611     Source Type: Journal    
DOI: 10.1097/CND.0b013e3181b51833     Document Type: Letter

References (10)

1. Bushby K, Muntoni F, Bourke JP. 107th ENMC international workshop: the management of cardiac involvement in muscular dystrophy and myotonic dystrophy. 7th-9th June 2002, Naarden, The Netherlands. Neuromuscul Disord. 2003;13:166-172.
2. Finsterer J, Stollberger C. The heart in human dystrophinopathies. Cardiology. 2003;99:1-19.
3. Diaz Buschmann C, Ruiz Falco ML, Tamariz Martel Moreno A, et al. Repeated cerebral infarction in a patient with Duchenne's muscular dystrophy [in French]. Rev Neurol (Paris). 2004;38:533-536.
4. Ikeniwa C, Sakai M, Kimura S, et al. Two cases of Duchenne muscular dystrophy complicated with dilated cardiomyopathy and cerebral infarction [in Japanese]. No To Shinkei. 2006;58:250-255.
5. Hanajima R, Kawai M. Incidence of cerebral infarction in Duchenne muscular dystrophy. Muscle Nerve. 1996;19:928.
6. Duboc D, Meune C, Lerebours G, et al. Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy. J Am Coll Cardiol. 2005;45:855-857.
7. Rhodes J, Margossian R, Darras BT, et al. Safety and efficacy of carvedilol therapy for patients with dilated cardiomyopathy secondary to muscular dystrophy. Pediatr Cardiol. 2008;29:343-351.
8. Samama MM. An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study. Arch Intern Med. 2000;160:3415-3420.
9. Saito T, Takenaka M, Miyai I, et al. Coagulation and fibrinolysis disorder in muscular dystrophy. Muscle Nerve. 2001;24:399-402.
10. Markham LW, Kinnett K, Wong BL, et al. Corticosteroid treatment retards development of ventricular dysfunction in Duchenne muscular dystrophy. Neuromuscul Disord. 2008;18:365-370.